Order Article Reprints

Dimitropoulos S, Mystakidi VC, Oikonomou E, Siasos G, Tsigkou V, Athanasiou D, Gouliopoulos N, Bletsa E, Kalampogias A, Charalambous G, et al. Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure. International Journal of Molecular Sciences. 2020; 21(24):9385. https://doi.org/10.3390/ijms21249385

Dimitropoulos, Stathis, Vasiliki Chara Mystakidi, Evangelos Oikonomou, Gerasimos Siasos, Vasiliki Tsigkou, Dimitris Athanasiou, Nikolaos Gouliopoulos, Evanthia Bletsa, Aimilios Kalampogias, Georgios Charalambous, and et al. 2020. "Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure" International Journal of Molecular Sciences 21, no. 24: 9385. https://doi.org/10.3390/ijms21249385

Dimitropoulos, S., Mystakidi, V. C., Oikonomou, E., Siasos, G., Tsigkou, V., Athanasiou, D., Gouliopoulos, N., Bletsa, E., Kalampogias, A., Charalambous, G., Tsioufis, C., Vavuranakis, M., & Tousoulis, D. (2020). Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure. International Journal of Molecular Sciences, 21(24), 9385. https://doi.org/10.3390/ijms21249385